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Abstract
Objectives: We aim to determine the prevalence and the course of anxiety and mood
disorders in Dutch adolescents (12–18 years old) with type 1 diabetes, and to exam-
ine correlates of symptom severity, including parental emotional distress.
Methods: Participants were 171 adolescents and 149 parents. The Diagnostic Inter-
view Schedule for Children-IV was used to assess current, past year and lifetime anxi-
ety and mood disorders in adolescents. Symptom severity and diabetes distress were
measured with validated questionnaires. Correlates of these symptoms were exam-
ined using hierarchical regression analyses and included demographics (adolescent
sex and age), clinical factors (diabetes duration, treatment modality, most recent gly-
cated hemoglobin A1c; all extracted from medical charts), adolescent diabetes dis-
tress, and parent emotional distress.
Results: Twenty-four (14%) adolescents met the criteria for ≥1 disorder(s) in the pre-
vious 12 months. Anxiety disorders were more prevalent than mood disorders (13%
vs. 4%). Lifetime prevalence of anxiety and mood disorders was 29% (n = 49). The
presence of any of these disorders earlier in life (from 5 years old up to 12 months
prior to assessment) was associated with disorders in the past 12 months (OR = 4.88,
p = 0.001). Higher adolescent diabetes distress was related to higher symptoms of
anxiety (b = 0.07, p = 0.001) and depression (b = 0.13, p = 0.001), while demo-
graphics, clinical characteristics, and parental emotional distress were not related.
Conclusions: Anxiety and mood disorders are common among adolescents and
related to earlier disorders. Higher diabetes distress was related to higher symptom
severity. Clinicians are advised to address past psychological problems and remain
vigilant of these problems.
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1 | INTRODUCTION
Adolescence is a period of risk for the development of anxiety and
depression.1,2 Living with type 1 diabetes (T1D) may augment this vul-
nerability. Unfortunately, exact estimates are lacking. Systematic
reviews addressing the prevalence of anxiety or depression in youth
with T1D only included studies using self-report questionnaires.3,4
Meta-analysis showed a pooled prevalence of 30% for questionnaire-
based depression and 32% for questionnaire-based anxiety. 4 The few
studies that used a diagnostic interview (presented in Table 1), the
gold standard in assessing the presence of psychiatric disorders, had a
small sample size,5-8 were conducted over 20 years ago,5,6 or failed to
report adolescent specific rates.6,8-10 As adolescents are developmen-
tally distinct from other age groups, adolescent-specific estimates are
needed. Furthermore, current and previous disorders should be con-
sidered simultaneously to better understand the underlying vulnera-
bility and course of these disorders.11
Psychiatric disorders in young people with T1D have been related
to suboptimal glycemic outcomes and lower quality of life,9 and psy-
chiatric disorders later in adulthood.12 Factors related to higher anxi-
ety or depressive symptoms include female gender, older age, and
ethnic minority group status.13,14 Insulin pump therapy, less frequent
blood glucose monitoring, and higher HbA1c were associated with
higher anxiety,15 while longer diabetes duration and suboptimal glyce-
mic control7,16 were associated with increased depressive symptoms.
As for psychological factors, higher adolescent diabetes distress has
been related to increased depressive symptoms.17 An important limi-
tation of previous studies is the focus on adolescent-centered
correlates. The link between parental and adolescent psychological func-
tioning is overlooked, even though studies in the general population have
shown a bidirectional transmission of negative affect between parents
and children.18,19 In the context of T1D, both diabetes-related and gen-
eral parental emotional distress could be of importance,20-23 but to our
knowledge have rarely both been integrated in studies examining emo-
tional problems in adolescents with T1D.
Therefore, we aim to: (1) determine the prevalence and course of
anxiety and mood disorders in Dutch adolescents with T1D, and
(2) examine whether demographic and clinical characteristics, adoles-
cent diabetes distress, and parental distress are related to the severity
of adolescent anxiety and depressive symptoms.
2 | PATIENTS AND METHODS
2.1 | Procedure and participants
Baseline data from the first pediatric diabetes clinics participating in
the ongoing Longitudinal study of Emotional problems in Adolescents
with T1D and their Parents/caregivers (Diabetes LEAP) were used.
Adolescents with T1D aged 12–18 years were recruited at Diabeter
(locations Deventer, Rotterdam, Schiphol, Veldhoven), Meander Medi-
cal Center Amersfoort, and Albert Schweitzer hospital Dordrecht, as
was the parent/caregiver primarily involved in their diabetes care.
Exclusion criteria were: (a) diabetes duration <6 months,
(b) intellectual disability, (c) insufficient mastery of the Dutch language,
or (d) severe circumstances interfering with participation. Eligible families
TABLE 1 Overview of studies assessing anxiety and mood disorders in adolescents with type 1 diabetes
Authors (year)
Sample
size Interview Timeframe Prevalence rates
Blanz et al.
(1993)5
N = 92 Semi-structured interview for the
psychiatric assessment of children
developed by Graham and Rutter




N = 92 Interview Schedule for Children and
Adolescents (ISCA)
From diagnosis up to
10 year follow-up
Anxiety disorders: 19.6% (N = 18)
Major depression or dysthymic
disorder: 26.1% (N = 24)
Northam et al.
(2004)7
N = 41 Diagnostic Interview for Children and
Adolescents—Version Four (DICA-IV)
Current (after 10 years of
diagnosis)
Anxiety disorders: 17.1% (N = 7)
Mood disorders: 17.1% (N = 7)
Liakopoulou
et al. (2001)8
N = 55 Schedule for Affective Disorders and
Schizophrenia for School-Age Children
(KSADS-P)
Current Prevalence rates not reported
Butwicka et al.
(2016)9
N = 207 Schedule for Affective Disorders and
Schizophrenia for Children—Present and
Lifetime version (KSADS-PL)
Current Anxiety disorders: 11.6% (N = 24)
Mood disorders: 3.9% (N = 8)
Lifetime Anxiety disorders: 15% (N = 31)
Mood disorders: 4.3% (N = 9)
Berger et al.
(2018)10
N = 241 Children's Diagnostic Interview for
Psychiatric Disorders (CDI-MD)
Current and lifetime Anxiety disorders*: 21.2% (N = 51)
Depression (all subtypes) and
dysthymia: 12.4% (N = 30)
Note: We summed the separate rates for disorder, agoraphobia, specific (isolated) phobias, social phobia, obsessive–compulsive disorder, generalized
anxiety disorder, and posttraumatic stress disorder to obtain an overall prevalence rate of anxiety disorders.
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were sent information about the study. Participation was discussed at the
next regular clinic visit. Parent participation was only possible if the adoles-
cent agreed to participate. Informed consent was obtained from all partici-
pants. The Medical Ethical Review Committee of Máxima Medical Center
Veldhoven approved the study (NL48232.015.14).
2.2 | Measures
2.2.1 | Demographic and clinical characteristics
Adolescent sex, birthdate, diagnosis-date, treatment modality (multi-
ple daily injections [MDI] or continuous subcutaneous insulin infusion
[CSII]), and HbA1c were extracted from medical records. HbA1c values
≥58 mmol/mol (7.5%) were considered suboptimal.24 Age and sex of
the primary caregiver were self-reported.
2.2.2 | Adolescent anxiety and mood disorders/
symptoms
To systematically assess anxiety and mood disorders, the Dutch trans-
lation of the Diagnostic Interview Schedule for Children –IV (DISC-IV)
was employed.25 An overview of the assessed disorders is presented
in Figure 1. Parents were not present for the interview. The inter-
views were conducted by members of the research team (medical psy-
chologists, MSc or PhD), by students (master's level Medical
Psychology), and trained research assistants. While the interview is
suitable to be used by laypersons, all students followed mandatory
training prior to conducting the interviews. The training consisted of a
workshop, observing interviews of a research team-member, and con-
ducting interviews under supervision of a research team-member. The
introductory module (demographic questions and the construction of
a timeline based on life-events) and the modules assessing the pres-
ence of anxiety and mood disorders in previous 4 weeks and the pre-
vious 12 months were used. A module concerning phobic fear of
hypoglycemia was added to the interview, directly adapted from the
Specific Phobia module of the DISC-IV. We replaced the question
segment describing a fear assessed in the Specific Phobia module,
such as “…heights…” with “…hypoglycemia….” The Whole Life screen-
ing module was used to assess occurrence of anxiety and/or mood
disorders from the age of 5 up to 12 months prior to assessment.
Results were summed into separate binary variables for the previous
4 weeks, the previous 12 months, and in earlier life separately, all
coded with values 0 (disorder not present) and 1 (disorder present).
Based on these three variables, we computed the lifetime presence of
Anxiety disorders Social phobia
Separation anxiety disorder
Specific phobia, containing fear of
- Dogs, birds, snakes, insects, or other animals
- Heights
- Storms
- Darkness/ the dark
- Water, e.g. a pool or a lake
- Crossing bridges, going through tunnels, travelling on a highway
- Riding an elevator of an escalator
- Needles, or receiving a shot 
- Seeing blood or wounds











F IGURE 1 Overview of the assessed
mood and anxiety disorders
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disorders, coded with value 0 (did not experience a disorder during
lifetime) and 1 (experienced [a] disorder[s] during lifetime).
Depressive symptoms in the past 2 weeks were assessed using
the Children's Depression Inventory (CDI)-2nd edition which consists
of 28 items, each rated from 0 to 2.26 The CDI has widely been used
in pediatric diabetes studies.4 Item scores were recoded if necessary
and summed into a total score with higher scores indicating more
depressive symptoms (range 0–56).26 A maximum of three missing
values was permitted, as a prorated score could be computed by mul-
tiplying the obtained raw score by 28, divided by the number of com-
pleted items of the total scale. The internal consistency was good in
the present study (α = 0.83).
To assess anxiety severity, the Generalized Anxiety Disorder-7
(GAD-7) was used.27 This short, validated self-report questionnaire
contains items about how often anxiety symptoms were experienced
in the past 2 weeks. Response options ranged from 0 (not at all) to
3 (nearly every day). A total score was computed by summing the
seven item responses (range 0–21). One missing response was permit-
ted, in which case person mean imputation was applied. While the
GAD-7 was initially developed for adult samples, it has also been
shown to detect clinically relevant anxiety in adolescents with a gen-
eralized anxiety disorder.28 The internal consistency was accept-
able (α = 0.72).
2.2.3 | Parental general emotional distress
The GAD-7 and the Patient Health Questionnaire–9 (PHQ-9) were
used to assess anxiety and depression in parents.27,29 The internal
consistencies were good (α = 0.87 and 0.81). The PHQ-9 contains
items describing how often depressive symptoms were present in the
past 2 weeks, with response options ranging from 0 (not at all) to
3 (nearly every day). A total score was obtained by summing the item
responses (range 0–27). Up to three missing values were permitted, in
which case a person's own mean score was imputed for that person.
2.2.4 | Diabetes-specific distress
Diabetes-specific distress in adolescents was measured using the
Problem Areas in Diabetes – Teens (PAID-T) questionnaire.30 The
PAID-T consists of 26 items describing aspects of diabetes (self-care)
to which the adolescents rated whether they experienced (emotional)
problems with these aspects, ranging from 1 (not a problem) to 6 (seri-
ous problem). A total score was computed by summing responses
(range 26–156), with higher scores indicating higher levels of distress.
Internal consistency was very good (α = 0.93).
Parental diabetes-specific distress was assessed using the Prob-
lem Areas in Diabetes – Parent Revised (PAID-PR).31 This 18-item val-
idated self-report questionnaire contains questions about the burden
of having a child with type 1 diabetes. Response options ranged from
0 (agree) to 4 (disagree). Item scores were reverse scored so higher
scores reflect higher levels of distress. A mean score of all items was
computed and multiplied by 25 into a total score (range 0–100) as
instructed in the PAID-PR scoring manual. The internal consistency
was very good (α = 0.91).
2.2.5 | Power analysis and statistical analyses
G*Power was used to conduct a power analysis. To detect a small to
medium effect size (0.02 < f2 < 0.15) between the nine individual pre-
dictors and the dependent variables, with a power of 0.80, alpha at
0.05, a minimum sample size range of 55–395 is required.
Statistical analyses were performed using SPSS 24.0. Descriptive sta-
tistics were applied to examine the sample characteristics and the preva-
lence of anxiety and depression in adolescents. Pearson Chi-square tests
or Fisher's exact tests (expected cell counts <5%) were conducted to
examine the association between past year emotional problems and ear-
lier lifetime emotional problems. Two hierarchical regression analyses
were conducted to examine correlates of adolescent anxiety (GAD-7
score) and depression (CDI-2 score) severity. Only adolescent-parent
dyads with complete data were included in these analyses (n = 147). The
correlates were entered in the following blocks: (1) adolescent age and
sex, (2) HbA1c (continuous), diabetes duration, and insulin pump therapy,
(3) adolescent diabetes-specific distress (PAID-T score), and (4) parental
distress: anxiety symptoms (GAD-7 score), depressive symptoms (PHQ-9
score), diabetes-specific distress (PAID-PR score). We inspected the
assumptions for linearity and homoscedasticity (standardized residuals
vs. standardized predicted values plots, histograms, P–P plots), normality
of residuals (histograms, P–P plots), multicollinearity (correlations, variance
inflation factor, and tolerance scores), and independent errors (Durbin-
Watson tests). Regarding the assumption of homoscedasticity there were
some concerns for both models. Therefore, robust regression analyses
were used by bootstrapping on 1000 subsamples.32 Post-hoc indepen-
dent t-tests were conducted to exploratively examine whether adoles-
cents depressive and anxiety symptoms differed between parental
education level groups (no, low and medium education vs. high), and
whether adjustment for adolescent depressive symptoms in the anxiety
severity model and vice versa yielded different results. Statistical signifi-
cance was set at p < 0.05.
3 | RESULTS
Characteristics of the adolescents (N = 171) and parents (N = 149) are
presented in Table 2. Adolescent anxiety symptoms and depressive
symptoms did not differ by parental education level (no, low, medium
vs. high; data not shown).
3.1 | Prevalence and course of anxiety and mood
disorders
Forty-nine adolescents (29%) have had an anxiety or mood disorder
during their lifetime. Anxiety disorders were more prevalent than
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mood disorders during lifetime (26% vs. 7%, Table 3). Twenty-four
adolescents (14%) appeared to have had (an) anxiety and/or mood
disorder(s) in the past year.
Twenty-three adolescents (13%) had an anxiety disorder in the
past year, of whom 16 reported the presence of an anxiety disorder in
the past 4 weeks. Specific phobias (n = 15) were most common,
followed by social phobia (n = 6), and obsessive–compulsive disorder
(n = 5). The most common phobia endorsed was fear of animals
(n = 7), while fear of needles (n = 1) and fear of blood and injury (n = 1)
were less prevalent. Mood disorders (past year) were present in 4%
(n = 7) of the adolescents, with major depression being the most com-
mon disorder (n = 4). Three adolescents had a mood disorder in the
past 4 weeks. Of the 171 adolescents, 6% (n = 10) had more than one
disorder in the past year.
TABLE 2 Sample characteristics of adolescents (n = 171) with type 1 diabetes and their parents (n = 149)
Missing values % (n) Mean ± SD (median; interquartile range) Range
Demographic characteristics
Age adolescent (years) 0 15 ± 2 (15; 13–17) 12–19
Female sex adolescent 0 47% (81)
Education level adolescent 1
Primary school 11% (19)
High school 76% (129)
Secondary vocational education 12% (20)
Secondary professional education 1% (2)
University 0% (0)
Being an only child, yes 22 12% (18)
Age parent (years) 2 46 ± 5 (46; 43–49) 34–59
Sex parent, women 1 89% (132)
Parent from (non-Dutch) ethnic minority group 1 3% (5)
Relationship status parent, being single 1 12% (17)






Diabetes duration (years) 0 7 ± 4 (7; 3–11) 0–16
Insulin treatment modality, CSII 0 78% (134)
Most recent HbA1c, % 0 7.7 ± 1 (7.8; 6.9–8.3) 5.1–11.5
Most recent HbA1c, mmol/mol 0 61 ± 12 (62; 52–67) 33–102
Optimal glycemic control (<7.5%/58 mmol/mol)b 42% (71)
Psychosocial characteristics
Anxiety symptoms (GAD-7) 4 2.9 ± 2.7 (3.0; 1.0–4.0) 0–13
Depressive symptoms adolescents (CDI-2) 4 6.2 ± 5.0 (5.0; 3.0–8.0) 0–26
Diabetes distress adolescent (PAID-T) 4 54.3 ± 19.3 (52.0; 38.0–68.0) 26–105
Anxiety symptoms parent (GAD-7) 0 2.4 ± 3.0 (2.0; 0.0–4.0) 0–14
Depressive symptoms parent (PHQ-9) 0 2.3 ± 3.0 (1.0; 0.0–3.0) 0–16
Diabetes distress parent (PAID-PR) 0 21.7 ± 15.9 (18.1; 9.72–29.2) 0–75
Note: Reported are valid percentages. Due to scheduling issues, one adolescent was 11.99 years old at assessment and two adolescents had a diabetes
duration of less than 6 months (0.55 and 0.56 years).
Abbreviations: CDI-2, children's depression inventory - 2nd edition; CSII, Continuous subcutaneous insulin infusion; DISC-IV, diagnostic interview schedule
for children – 4th edition; GAD-7, generalized anxiety disorder – 7 item anxiety scale; HbA1c, glycated hemoglobin A1c; PAID-PR, problem areas in
diabetes –parents revised; PAID-T, problem areas in diabetes – teens; PHQ-9, patient health questionnaire – 9 item depression scale.
aLow: no education, primary school, lower vocational education; Moderate: (Secondary) Vocational education; High: (Secondary) Higher professional
education and university.
bWhen a cut-off of 7.0% or 53 mmol/mol was used, 26% (n = 44) adolescents were in optimal control.
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TABLE 3 The prevalence of anxiety and/or mood disorders in adolescents (n = 171) in the past 4 weeks, the past year, and during lifetime
(≥5 years old)
Past 4 weeks Past year Lifetime
Anxiety disorders Social phobia 2% (3) 4% (6) 7% (12)
Separation anxiety disorder 0% (0) 0.6% (1) 5% (8)
Specific phobia 7% (12) 9% (15) 15% (26)
Phobic fear of hypoglycemia 1% (2) 2% (3) 5% (8)
Panic disorder 0% (0) 0% (0) 2% (3)
Agoraphobia 0% (0) 0% (0) 2% (3)
Generalized anxiety disorder 0.6% (1) 2% (3) 4% (6)
Selective mutism 0% (0) 0.6% (1) 0.6% (1)
Obsessive compulsive disorder 2% (3) 3% (5) 3% (5)
Post-traumatic stress disorder 0% (0) 0.6% (1) 0.6% (1)a
Prevalence of anxiety disorder(s) 9% (16) 13% (23) 26% (44)
Mood disorders Major depression 1% (2) 2% (4) 4.7% (8)
Dysthymia 0.6% (1) 1% (2) 1.2% (2)b
Mania 0% (0) 0% (0) 0.6% (1)
Hypomania 0% (0) 1% (2) 1.2% (2)c
Prevalence of mood disorder(s) 2% (3) 4% (7) 7% (12)
Total 9% (16) 14% (24) 29% (49)
Note: Reported are percentages (n). Past year prevalence also includes 4 week prevalence. Lifetime prevalence also includes past year-prevalence.
aLifetime occurrence of post-traumatic stress disorder was embedded in the diagnostic module.
bLifetime occurrence of dysthymia was not assessed in the whole life module. Lifetime occurrence of decreased mood was assessed in the whole life
Major depression screening.




























No disorder present 
N= 122
Earlier life Past year Past four weeks F IGURE 2 Overview of the number
of disorders per timeframe among
adolescents with type 1 diabetes
6 NGUYEN ET AL.
Of the 147 adolescents who did not have emotional problems in
the past year, 25 (17%) had a disorder earlier in life. Of this group,
21 adolescents reported earlier anxiety disorders, while four
reported earlier mood disorders. Ten of the 25 adolescents (40%)
had contacted a (mental) health care professional for these
problems.
Out of the adolescents who did not have a history of anxiety or
mood disorders (n = 134), 12 (9%) had an anxiety and/or mood disor-
der in the past year. Of the 24 adolescents who had an anxiety and/or
mood disorder in the past year, 50% (12) also appeared to have had
earlier psychological problems. Eleven adolescents had an anxiety dis-
orders and one adolescent had a mood disorder earlier in life. Four
(33%) had contacted a (mental) health care professional for these
problems.
An overview of the number of disorders per timeframe is pres-
ented in Figure 2.
The presence of an emotional problem in earlier life was strongly
and significantly associated with the presence of an emotional prob-
lem in the past year (Χ2 (1) = 13, p < 0.001, odds ratio [OR] = 4.88,
95% CI 1.97–12.11). Earlier life anxiety disorders were also strongly
associated with past year presence of anxiety disorders (p = 0.001,
OR = 5.54, 95% CI 2.17–14.18) and mood disorders (p = 0.003,
OR = 12.69, 95% CI 2.34–68.81). However, earlier life mood disorders
were not associated with past year anxiety disorders (p = 0.52) or
mood disorders (p > 0.99).
3.2 | Correlates of anxiety severity
In the first step of bootstrapped hierarchical regression analysis
(Table 4), demographic characteristics accounted for 7% of the vari-
ance in anxiety severity and the model significantly fit the data
(p = 0.002). After adding clinical characteristics, 9% of the variance in
anxiety severity was explained (p = 0.08). Adding adolescent diabetes
distress to the model led to a significant improvement of explained
variance (27%, p < 0.001). Lastly, parental general emotional and
diabetes-specific distress were added, but did not significantly
improve the model (p = 0.49). In this final model, accounting for 27%
of the variance in anxiety severity, higher adolescent diabetes distress
was the only factor significantly related to higher anxiety severity
(p = 0.001). After including adolescent depressive symptoms (CDI-2
score) (post hoc analysis), a total of 39% of the variance in anxiety
severity was explained. In this fully adjusted model, higher diabetes
distress (b = 0.04, 95% BCa = 0.02–0.06, p = 0.002) and higher
depression severity (b = 0.23, 95% BCa = 0.14–0.34, p = 0.001) were
related to higher anxiety severity.
TABLE 4 The association of adolescent anxiety severity (GAD-7 total score) with adolescent demographical characteristics, clinical
characteristics, adolescent diabetes-specific distress, and parental distress (n = 147)
Step 1 B
(95% BCa) Step 2 B (95% BCa) Step 3 B (95% BCa) Step 4 B (95% BCa)
Demographic
characteristics
Age adolescent (years) 0.21 (0.03–0.40)* 0.26 (0.04–0.47)* 0.10 (−0.10 to 0.29) 0.09 (−0.10 to 0.27)
Female sex adolescent 1.29 (0.47–2.19)** 1.25 (0.43–2.09)** 0.41 (−0.25 to 1.15) 0.39 (−0.30 to 1.12)
Clinical characteristics Diabetes duration (years) −0.08 (−0.20 to 0.04) −0.08 (−0.20 to 0.03) −0.08 (−0.19 to 0.03)
Insulin treatment
modality, CSII
−1.01 (−2.32 to 0.24) −0.91 (−2.02 to 0.22) −0.99 (−2.10 to 0.08)
Most recent HbA1c
(mmol/mol)





0.07 (0.05–0.09)** 0.07 (0.05–0.09)**
Parental distress Anxiety symptoms (GAD-
7)
−0.07 (−0.30 to 0.13)
Depressive symptoms
(PHQ-9)
0.12 (−0.09 to 0.34)
Diabetes distress (PAID-
PR)
−0.01 (−0.05 to 0.02)
Adjusted R2 0.07** 0.09** 0.27** 0.27**
R2 change 0.08** 0.04 0.18** 0.01
Note: Reported are the bootstrapped unstandardized regression coefficients and the 95% bias corrected accelerated confidence interval, and the
proportion of explained variance. Results from post-hoc analyses were not included in this table. Sex adolescent was binary coded as boy = 0 versus
girl = 1; insulin treatment modality as multiple daily self-injections = 0 versus continuous subcutaneous insulin infusion = 1. Adjusted R2 reported the fit of
the regression model adjusted for the number of predictor variables. R2 change signified whether each hierarchical block significantly improved the fit of
the regression model.
*p < 0.05; **p < 0.01; ***p < 0.001.
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3.3 | Correlates of depression severity
Demographic characteristics explained 6% of the variance in depression
severity (p = 0.003, Table 5). Adding clinical characteristics added 8%
explained variance, with no significant improvement (p = 0.14). Adding
adolescent diabetes-distress led to a significant improvement to the
model explaining a total of 31% variance in depression severity
(p < 0.001). Lastly, adding parental general emotional and diabetes-
specific distress did not significantly improve the model (p = 0.08). In
this final model, higher adolescent diabetes distress was related to
more severe depression (p = 0.001), but the other factors were
not. After including adolescent anxiety symptoms (GAD-7 score)
(post hoc analysis), 44% of the variance in depression severity was
explained, with higher adolescent diabetes distress (b = 0.08, 95%
BCa = 0.04–0.12, p = 0.002) and anxiety severity (b = 0.75, 95%
BCa 0.43–1.09, p = 0.001) being related to higher depression
severity.
4 | DISCUSSION
Almost one-in-three adolescents with T1D reported a lifetime anxiety
or mood disorder and 14% had a past year anxiety or mood disorder.
Anxiety disorders were more prevalent than mood disorders, consis-
tent with earlier studies33 and most studies in adolescents with
T1D.5,8,10 Due to the different time frames used (e.g., lifetime
prevalence,9,10 10-year prevalence of newly diagnosed children,6 cur-
rent prevalence9), it is difficult to directly compare rates between
studies. The four-week prevalence of anxiety disorders in our study
(9%) appears to be lower than the current rates reported in previous
studies (Table 1). Similarly, our prevalence rate of mood disorders in
the past 4 weeks (2%) appears to be lower than rates reported in pre-
vious studies (4%–12%).4,9
The lifetime prevalence of anxiety disorders does seem higher in
our sample (26%) compared with other studies in adolescents with
T1D (15%–21%),9,10 perhaps due to our adding phobic fear of hypo-
glycemia. After excluding fear of hypoglycemia, the lifetime preva-
lence of anxiety disorders in our (21%) and other studies in
adolescents with T1D is lower than the 28% reported for the general
Dutch adolescent population.33 The same trend is found for lifetime
prevalence of mood disorders, where the estimates in our (7%) and
previous studies in adolescents with type 1 diabetes (4%–12%)9,10 are
lower than the 17% reported in the general Dutch adolescent popula-
tion.33 There are several potential explanations for this difference.
Firstly, these general population estimates are based on adolescents
from one Dutch region, while we included young people from across
the country. Secondly, youth with T1D regularly consult with their
diabetes teams, with more opportunities for early detection of (sub-
clinical) emotional problems and to offer psychosocial support, com-
pared to adolescents without diabetes.34 Thirdly, the possibility of
developing emotional problems is normalized in diabetes care. With-
out this explicit attention to emotional problems, youth (and their
TABLE 5 The association between adolescent demographical characteristics, clinical characteristics, adolescent diabetes-specific distress, and
parental distress with adolescent depression severity (n = 147)
Step 1 B (95% BCa) Step 2 B (95% BCa) Step 3 B (95% BCa) Step 4 B (95% BCa)
Demographic
characteristics
Age adolescent (years) 0.21 (−0.15 to 0.59) 0.21 (−0.21 to 0.67) −0.14(−0.52 to 0.27) −0.09 (−0.46 to 0.32)





−0.10 (−0.29 to 0.10) −0.11 (−0.27 to 0.07) −0.14 (−0.30 to 0.03)
Insulin treatment
modality, CSII
−1.23 (−3.39 to 0.95) −1.01 (−2.89 to 0.75) −1.09 (−2.80 to 0.62)
Most recent HbA1c
(mmol/mol)





0.14 (0.10–0.19)** 0.13 (0.09–0.17)**
Parental distress Anxiety symptoms
(GAD-7)
−0.29 (−0.70 to 0.14)
Depressive symptoms
(PHQ-9)
0.36 (−0.04 to 0.76)
Diabetes distress
(PAID-PR)
0.04 (−0.02 to 0.10)
Adjusted R2 0.06** 0.08** 0.31** 0.33**
R2 change 0.08** 0.03 0.23** 0.03
Note: Reported are the bootstrapped regression coefficients and the 95% bias corrected accelerated confidence interval, and the proportion of explained
variance. Results from post-hoc analyses were not included in this table. Sex adolescent was binary coded as boy = 0 versus girl = 1; insulin treatment
modality as multiple daily self-injections = 0 versus continuous subcutaneous insulin infusion = 1. Adjusted R2 reported the fit of the regression model
adjusted for the number of predictor variables. R2 change signified whether each hierarchical block significantly improved the fit of the regression model.
*p < 0.05; **p < 0.01; ***p < 0.001.
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parents) may find it more difficult to recognize symptoms35 or per-
ceive more related stigma, delaying help-seeking.35
Though overall rates of anxiety and mood disorders appear lower
in the present sample of adolescents with T1D compared with rates in
the general population,33 it is important recognize and treat these
conditions in this group, as these problems have a strong negative
impact on quality of life, contribute to suboptimal diabetes manage-
ment and impact diabetes outcomes. Adolescents who had emotional
problems earlier in life were more likely to have emotional problems
in the past year, corroborating evidence that earlier disorders increase
risk for future disorders.6 Coupled with the finding that less than half
of the adolescents who had anxiety or mood disorders earlier in life
had contacted a (mental) health care professional for these problems,
this stresses the value of continued vigilance of health care profes-
sionals concerning emotional symptoms and the importance of
addressing attitudes toward mental health care. Similar to the general
population, families may not always feel the need for specialized
treatment, for example when symptoms are considered transient or
when self-reliance is preferred over formal treatment.35 The final
decision about whether or not to initiate professional psychological
treatment generally rests with adolescents and their families, but
health care professionals do have a responsibility to provide them
with all the information necessary (e.g., about the chronicity of symp-
toms) to make a decision and to address any potentially harmful
barriers.
With respect to correlates of symptom severity, we expected
older age, female gender, longer diabetes duration, insulin pump ther-
apy, and suboptimal glycemic control to be related to anxiety and
depression severity,7,13-16 but these associations were not replicated
in the present study. The relatively mild severity of anxiety and
depressive symptoms could have undermined the power to detect
these hypothesized associations. Our results did show that higher
adolescent diabetes-specific distress is related to higher adolescent
anxiety and depression severity, in accordance with Powers et al.
(2017).17 Diabetes-specific distress could be an important contributor
to more general emotional distress.17 which in its most severe form
could manifest as major depression,36 but confusing diabetes distress
with psychiatric disorders can lead to ineffective treatment.
We did not find parental distress to be associated with adolescent
anxiety or depression severity, contrasting earlier findings.20-22 While
other factors could counteract the negative effects of parental prob-
lems on children (e.g., relying on and spending time with other peo-
ple), adolescents themselves may also be more resilient to parental
distress than previously reported. It should be noted that these earlier
studies only included mothers20 and did not focus on adolescents spe-
cifically.22 Furthermore, our results could be result of developmental
processes, in which adolescents spend less time and rely less on par-
ents as they progress through the developmental stage. It could also
be the case that parental distress is not directly associated with ado-
lescent emotional distress, but rather indirectly through the way par-
ents interact with their child. In a previous study, parental depressive
symptoms were associated with lower parental warmth, and in turn
lower parental warmth was associated with higher severity of
depressive symptoms in youth with type 1 diabetes.37 Furthermore,
parental depressive symptoms were indirectly associated with higher
HbA1c, through lower parental monitoring.
37
While depression and anxiety have been a topic of previous
research interest, we have addressed important methodological limita-
tions and gaps in knowledge of existing studies. Thus, strengths of the
current study include the large sample size, the use of a structured
diagnostic psychiatric interview, the use of validated questionnaires,
and the inclusion of both adolescent and parental correlates of anxi-
ety/depression severity. However, there are also several limitations.
First, as we did not collect (mental health) data of non-participants,
selection bias cannot be ruled out, possibly threatening the generaliz-
ability of our results. Secondly, ethnic minorities were underrepre-
sented in the sample. Thirdly, the upper limit of the HbA1c values in
the present study does not represent the highest risk category.
Underrepresentation of adolescents with high HbA1c could have led
to an underestimation of cases, and limits the generalizability of our
results. Fourthly, the presence of disorders was determined retrospec-
tively at one measurement occasion, introducing the possibility of
recall bias. Specifically, the lifetime-module, which includes early child-
hood experiences (from the age of 5 years old), may be susceptible for
recall bias Including parent reports could provide more detailed infor-
mation, especially for the early years. Fifthly, the Phobic fear of
hypoglycemia-module was adapted from the Specific phobia-module
specifically for the present study and therefore lacks previous valida-
tion. While we kept the wording as close to the original phrasing as
possible, a validation study is needed to establish the reliability and
validity of this module. Sixthly, not all possibly relevant correlates of
anxiety/depression could be included in the model, as the sample size
did not permit the addition of more predictors increasing the risk of
overfitting the models. Socioeconomic status,38 for example, is a likely
contributor to distress and should be addressed in future research.
Further recommendations for future studies are to examine whether
interview-based symptom counts are related to diabetes-specific dis-
tress, whether there is a moderation effect of development stage
(i.e., early vs. late adolescence) in the relation between parental
distress and adolescent distress, and to examine anxiety and mood
disorders in this group relate to overall quality of life and diabetes
self-management. Finally, the cross-sectional observational data on
anxiety/depression severity and diabetes-specific distress preclude
inferences about causality.
Within pediatric diabetes care, clinical practice guidelines recog-
nize that emotional wellbeing of adolescents with type 1 diabetes
warrants attention. Our results show that adolescents with a history
of emotional problems are particularly at risk for subsequent emo-
tional problems, hence health-care providers are advised to not only
inquire about current symptoms, but also to pay attention to symp-
toms experienced in the past for a more comprehensive evaluation of
risk. A periodic stepped screening procedure using a validated mental
health screener could be valuable to track current emotional symp-
toms, but only when there are resources available to follow-up with
psychosocial support and/or treatment if necessary. While screening
instruments are useful in assessing the severity of emotional distress,
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the context in which the symptoms are experienced is at least as
important. Persistent feelings of sadness, for example, could be attrib-
uted to adjustment disorder, but also a mood or an anxiety disorder,
or diabetes-specific distress. An interpretation of screening-results by
a mental health professional is therefore warranted. Furthermore, the
addition of an optional check-in with a mental health professional to
the annual review appointments could improve the recognition of
psychological problems. As diabetes-specific distress is highly preva-
lent in adolescents with T1D39 and appeared to be uniquely related to
higher severity of anxiety and depression, psychologists specialized in
diabetes play an important role in care support. Understanding how
these factors interplay is crucial for effective treatment37 and atten-
tion to diabetes-specific topics should be part of the therapy content
when aiming to improve psychological wellbeing through evidence-
based techniques (e.g., cognitive behavioral therapy).40
5 | CONCLUSIONS
Mood disorders and particularly anxiety disorders are common in ado-
lescents with T1D and related to disorders earlier in life, warranting
continued vigilance by health-care providers. Diabetes-specific dis-
tress was uniquely related to higher symptom severity. Prospective
longitudinal studies are needed to provide insight into the directional-
ity of this association and into the further course of disorders across
adolescence and into adulthood.
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